Erika (Cawthron) Gill

Erika Gill is a purpose-driven executive with over 20 years of experience leading diverse teams across commercial functions in the biopharmaceutical industry. As Vice President and Head of Neuroscience Global Product and Launch Strategy at Takeda, Erika is recognized for her expertise in strategic planning, product development, and global market and ultra-rare launches. She has successfully led cross-functional teams in the development of global launch strategies for multiple Phase 3 assets and a $4B in-line commercial asset. 

Throughout her career, Erika has demonstrated a proven ability to build high-performing teams and drive impactful results. She has led the launch of five assets in the U.S. and globally, established go-to-market strategies, and managed complex alliances for co-promotion agreements. Erika has also overseen key initiatives in field leadership, commercial operations, and patient services, designing nursing, reimbursement, and case management programs, and managing multi-million dollar budgets to enhance customer experience and operational efficiency.

Erika holds a BS in Health Management and Policy from the University of New Hampshire and an MBA from Boston University.

Connect with Erika Gill on LinkedIn.